Obesity & Diabetes
Normal and insulin-resistant models respond differently to linoleic acid
Published in Obesity and Diabetes Week, August 9th, 2004
According to published research from Canada, "Dietary conjugated linoleic acid (CLA) is being investigated for beneficial effects for disease prevention and treatment in a variety of experimental models, including obesity and type 2 diabetes. To date, rodent studies suggest that trans-10,cis-12 (t10,02) CLA is associated with greater insulin resistance, despite lower body fat, and that a CLA mixture (and perhaps c9,t11) could be beneficial for the management of insulin resistance."
"Studies investigating the mechanisms by which CLA operates at the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Lipid-induced mitochondrial damage plays role in type 2 diabetes development - Diabetes Pathogenesis
RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets - Diabetes Therapy
Novel PPAR-alpha/-gamma agonists are antihyperglycemic and hypolipidemic - Obesity and Diabetes
Catabolic action of insulin not enhanced by exogenous 'tub' expression - Atherosclerosis Therapy
Probucol and ticlopidine aid hyperlipidemic patients with type 2 diabetes - Breastfeeding
Obese mothers have weaker biological response to infant suckling - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
